Cargando…
Public investments in the development of GeneXpert molecular diagnostic technology
BACKGROUND: The GeneXpert diagnostic platform from the US based company Cepheid is an automated molecular diagnostic device that performs sample preparation and pathogen detection within a single cartridge-based assay. GeneXpert devices can enable diagnosis at the district level without the need for...
Autores principales: | Gotham, Dzintars, McKenna, Lindsay, Deborggraeve, Stijn, Madoori, Suraj, Branigan, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407584/ https://www.ncbi.nlm.nih.gov/pubmed/34464413 http://dx.doi.org/10.1371/journal.pone.0256883 |
Ejemplares similares
-
Public investments in the clinical development of bedaquiline
por: Gotham, Dzintars, et al.
Publicado: (2020) -
GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019) -
Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021) -
Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis
por: Umair, Masab, et al.
Publicado: (2020) -
Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)